"PREFACE This report contains a summary of the data compiled during the evaluation of the test compound. The report is organized to present the results in a concise and easily interpretable manner. The first part contains items I-VIII. Items I-IV provide sponsor and compound identification information@ type of assay@ and the protocol reference number. ATI protocol references indicate a general procedure described In the Litton Bionetics@ Inc. ""Screening Program for the Identification of Potential Mutagens and Carcinogens."" Item VI identifies the supervisory personnel. Item VII identifies the tables and/or figures containing the data used by the study director in interpreting the test results. The interpretation itself is in Item VIII. Item IX provides the conclusion and evaluation. The second part of the report@ entitled STUDY DESIGN@ describes the materials and procedures employed in conducting the assay. This part of the report also contains evaluation criteria used by the study director@ and any appendices. All test and control results presented in this report are supported by raw data which are permanently maintained in the files of the Department of Genetics and Cell Biology or in the archives of Litton Bionetics@ Inc.@ 5516 Nicholson Lane@ Kensington@ Maryland 20795. Copies of the raw data will be supplied to the sponsor upon request."